A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis

NCT03688555 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Bilateral Nasal Polyposis

Interventions

DRUG: ACT-774312
DRUG: Placebo

Sponsor

Idorsia Pharmaceuticals Ltd.